Identification and quantification of device extractables and leachables can now be outsourced to Aptar. The service is being offered after Aptar registered sites in Le Vaudreuil and Val-de-Reuil, France as contract testing laboratories with the US Food and Drug Administration (FDA).
“A number of pharmaceutical and biotechnology companies working with Aptar Pharma drug delivery devices have expressed a requirement to use Aptar Pharma extractables testing for batch release of their drug products”, said Aptar.